21-Methylmelianodiols from Poncirus trifoliata as inhibitors of interleukin-5 bioactivity in pro-B cells

Planta Medica

Volumn 74, Issue 4, 2008, Pages 396-400

  In, Jeong Lee ^a   Xu, Cuang Hua ^b   Ju, Ng Hun ^a   Jeong, Ah Kim ^b   Kwon, Soon Woo ^a   Seung, Ho Lee ^b   Han, Sang Bae ^a   Kim, Youngsoo ^a  

^a Chungbuk National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

21 methylmelianodiol; 21 methylmelianodiol; Il 5 inhibitor; Poncirus trifoliata; Pro B cells; Rutaceae

Indexed keywords

21ALPHA METHYLMELIANODIOL; 21BETA METHYLMELIANODIOL; ALKANEDIOL DERIVATIVE; INTERLEUKIN 5; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; FRACTIONATION; IC 50; NONHUMAN; TRIFOLIATE ORANGE;

CELL LINE; HUMANS; INTERLEUKIN-5; MOLECULAR STRUCTURE; PONCIRUS; PRECURSOR CELLS, B-LYMPHOID; TRITERPENES;

PONCIRUS TRIFOLIATA; RUTACEAE;

EID: 42549167385     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034329     Document Type: Article

References (13)

1. Bao S, Beagley KW, Murray AM, Caristo V, Matthaei KI, Young IG et al. Intestinal IgA plasma cells of the B1 lineage are IL-5 dependent. Immunology 1998; 94: 181-8
2. Zabeau L, Gevaert P, Bachert C, Tavernier J. Interleukin-5, eosinophilic diseases and therapeutic intervention. Curr Drug Targets Inflamm Allergy 2003; 2: 319-28
3. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201
4. Shardonofsky FR, Venzor J 3rd, Barrios R, Leong KP, Huston DP. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol 1999; 104: 215-21
5. Min B, Oh SR, Lee HK, Takatsu K, Chang IM, Min KR et al. Sophoricoside analogs as the IL-5 inhibitors from Sophora japonica. Planta Med 1999; 65: 408-12
6. Park KY, Lee SH, Min BK, Lee KS, Choi JS, Chung SR et al. Inhibitory effect of luteolin 4′-O-glucoside from Kummerowia striata and other flavonoids on interleukin-5 bioactivity. Planta Med 1999; 65: 457-9
7. Morokata T, Ida K, Yamada T. Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int Immunopharmacol 2002; 2: 1693-702
8. Wiekowski M, Presser D, Taremi S, Tsarbopoulos A, Jenh CH, Chou CC et al. Characterization of potential antagonists of human interleukin 5 demonstrates their cross-reactivity with receptors for interleukin 3 and granulocyte-macrophage colony-stimulating factor. Eur J Biochem 1997; 246: 625-32
9. Tominaga A, Mita S, Kikuchi Y, Hitoshi Y, Takatsu K, Nishikawa S et al. Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. Growth Fact 1989; 1: 135-46
10. Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R. Lyn, Jak2 and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998; 188: 421-9
11. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 1998; 5: 551-62
12. Shin TY, Oh JM, Choi BJ, Park WH, Kim CH, Jun CD et al. Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-κB activation in mast cells. Toxicol In Vitro 2006; 20: 1071-6
13. Pokharel YR, Jeong JE, Oh SJ, Kim SK, Woo ER, Kang KW. Screening of potential chemopreventive compounds from Poncirus trifoliata Raf. Pharmazie 2006; 61: 796-8